“I don't see any real big picture macro reasons, for near term underperformance, I think this sector, continues to rally throughout the the balance of the year.”
→ Read the source episode
XBI index shows net positive performance from 2026-08-04 through 2026-12-31
John predicts Coursera will run two studies (biomarker and outcomes-based) for their PCSK9/angiotensinogen siRNA program
Yaron Werber predicts Gilead's Anido Cell (anti-BCMA CAR-T) will receive FDA approval in December 2026
John predicts France will win the third-place match and Argentina will beat France 3-2 in the World Cup final on Sunday
Matt Klein's company will launch brepacitinib within the next two to two and a half months
Yaron Werber predicts Forte's phase 2b celiac disease study will be positive
Yaron Werber expects Forte will report phase 2b celiac and phase 1b alopecia areata data by end of 2026
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.